We serve Chemical Name:(4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid CAS:1072951-94-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid
CAS.NO:1072951-94-0
Synonyms:[4-[(3,5-dimethoxyphenyl)methoxy]-3,5-dimethylphenyl]boronic acid
Molecular Formula:C17H21BO5
Molecular Weight:316.15700
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:68.15000
Exact Mass:316.14800
LogP:1.57940
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like [4-[(3,5-dimethoxyphenyl)methoxy]-3,5-dimethylphenyl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[4-[(3,5-dimethoxyphenyl)methoxy]-3,5-dimethylphenyl]boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[4-[(3,5-dimethoxyphenyl)methoxy]-3,5-dimethylphenyl]boronic acid Use and application,[4-[(3,5-dimethoxyphenyl)methoxy]-3,5-dimethylphenyl]boronic acid technical grade,usp/ep/jp grade.
Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). (4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid manufacturer This is how an API becomes a medicine. (4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). (4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid vendor We partner with life science companies of all sizes, drawing on over 20 years of industry experience. (4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid factory Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).
